Literature DB >> 18799720

Elevated uric acid increases the risk for kidney disease.

Rudolf P Obermayr1, Christian Temml, Georg Gutjahr, Maarten Knechtelsdorfer, Rainer Oberbauer, Renate Klauser-Braun.   

Abstract

Recent epidemiologic studies suggest that uric acid predicts the development of new-onset kidney disease, but it is unclear whether uric acid is an independent risk factor. In this study, data from 21,475 healthy volunteers who were followed prospectively for a median of 7 yr were analyzed to examine the association between uric acid level and incident kidney disease (estimated GFR [eGFR] <60 ml/min per 1.73 m(2)). After adjustment for baseline eGFR, a slightly elevated uric acid level (7.0 to 8.9 mg/dl) was associated with a nearly doubled risk for incident kidney disease (odds ratio 1.74; 95% confidence interval 1.45 to 2.09), and an elevated uric acid (> or =9.0 mg/dl) was associated with a tripled risk (odds ratio 3.12; 95% confidence interval 2.29 to 4.25). These increases in risk remained significant even after adjustment for baseline eGFR, gender, age, antihypertensive drugs, and components of the metabolic syndrome (waist circumference, HDL cholesterol, blood glucose, triglycerides, and BP). In a fully adjusted spline model, the risk for incident kidney disease increased roughly linearly with uric acid level to a level of approximately 6 to 7 mg/dl in women and 7 to 8 mg/dl in men; above these levels, the associated risk increased rapidly. In conclusion, elevated levels of uric acid independently increase the risk for new-onset kidney disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799720      PMCID: PMC2588108          DOI: 10.1681/ASN.2008010080

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  40 in total

1.  Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers.

Authors:  M Tomita; S Mizuno; H Yamanaka; Y Hosoda; K Sakuma; Y Matuoka; M Odaka; M Yamaguchi; H Yosida; H Morisawa; T Murayama
Journal:  J Epidemiol       Date:  2000-11       Impact factor: 3.211

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 3.  Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

Authors:  Richard J Johnson; Duk-Hee Kang; Daniel Feig; Salah Kivlighn; John Kanellis; Susumu Watanabe; Katherine R Tuttle; Bernardo Rodriguez-Iturbe; Jaime Herrera-Acosta; Marilda Mazzali
Journal:  Hypertension       Date:  2003-04-21       Impact factor: 10.190

4.  Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.

Authors:  J Fang; M H Alderman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

5.  Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects.

Authors:  K Iseki; S Oshiro; M Tozawa; C Iseki; Y Ikemiya; S Takishita
Journal:  Hypertens Res       Date:  2001-11       Impact factor: 3.872

6.  Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.

Authors:  Bénédicte Stengel; Solenne Billon; Paul C W Van Dijk; Kitty J Jager; Friedo W Dekker; Keith Simpson; J Douglas Briggs
Journal:  Nephrol Dial Transplant       Date:  2003-09       Impact factor: 5.992

7.  A role for uric acid in the progression of renal disease.

Authors:  Duk-Hee Kang; Takahiko Nakagawa; Lili Feng; Susumu Watanabe; Lin Han; Marilda Mazzali; Luan Truong; Raymond Harris; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2002-12       Impact factor: 10.121

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Uric acid and incident kidney disease in the community.

Authors:  Daniel E Weiner; Hocine Tighiouart; Essam F Elsayed; John L Griffith; Deeb N Salem; Andrew S Levey
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

10.  Mild hyperuricemia and subclinical renal damage in untreated primary hypertension.

Authors:  Francesca Viazzi; Giovanna Leoncini; Elena Ratto; Valeria Falqui; Angelica Parodi; Novella Conti; Lorenzo E Derchi; Cinzia Tomolillo; Giacomo Deferrari; Roberto Pontremoli
Journal:  Am J Hypertens       Date:  2007-12       Impact factor: 2.689

View more
  204 in total

1.  Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Authors:  Stacey E Jolly; Mihriye Mete; Hong Wang; Jianhui Zhu; Sven O E Ebbesson; V Saroja Voruganti; Anthony G Comuzzie; Barbara V Howard; Jason G Umans
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-01-04       Impact factor: 3.738

2.  Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families.

Authors:  Andrew D Rule; Mariza de Andrade; Martha Matsumoto; Tom H Mosley; Sharon Kardia; Stephen T Turner
Journal:  Rheumatology (Oxford)       Date:  2010-12-24       Impact factor: 7.580

Review 3.  Uric acid as a mediator of diabetic nephropathy.

Authors:  Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

4.  Increased childhood BMI is associated with young adult serum uric acid levels: a linkage study from Japan.

Authors:  Erika Kuwahara; Yoshitaka Murakami; Tomonori Okamura; Hirokazu Komatsu; Akemi Nakazawa; Hideo Ushiku; Fumio Maejima; Yoshio Nishigaki; Yuji Nishiwaki
Journal:  Pediatr Res       Date:  2016-10-27       Impact factor: 3.756

Review 5.  Difficult-to-treat gouty arthritis: a disease warranting better management.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

Review 6.  Urate reduction and renal preservation: what is the evidence?

Authors:  Nicolas Macías; Marian Goicoechea; M S García de Vinuesa; Ursula Verdalles; Jose Luño
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

Review 7.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

8.  Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Andrew S Bomback; Ronit Katz; Ka He; David A Shoham; Gregory L Burke; Philip J Klemmer
Journal:  Am J Clin Nutr       Date:  2009-09-09       Impact factor: 7.045

Review 9.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 10.  Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.

Authors:  J L Pirkle; B I Freedman
Journal:  Minerva Urol Nefrol       Date:  2013-03       Impact factor: 3.720

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.